A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia

CompletedOBSERVATIONAL
Enrollment

71

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Rheumatoid Arthritis
Trial Locations (13)

10450

Site Reference ID/Investigator# 57913, George Town

25100

Site Reference ID/Investigator# 57928, Kuantan

30990

Site Reference ID/Investigator# 57914, Ipoh

41200

Site Reference ID/Investigator# 67602, Klang

43300

Site Reference ID/Investigator# 57926, Serdang

50586

Site Reference ID/Investigator# 57916, Kuala Lumpur

62250

Site Reference ID/Investigator# 57915, Putrajaya

68100

Site Reference ID/Investigator# 36098, Batu Caves

70300

Site Reference ID/Investigator# 57922, Seremban

75400

Site Reference ID/Investigator# 57927, Malacca

81100

Site Reference ID/Investigator# 57923, Johor Bahru

88586

Site Reference ID/Investigator# 57925, Kota Kinabalu

93590

Site Reference ID/Investigator# 57924, Kuching

All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01387789 - A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia | Biotech Hunter | Biotech Hunter